GOSERELIN - 16 Annonces

Friday 22 August 2025

Goserelin is a gonadorelin analog with similar effects, and was approved for marketing in France in 1987. Goserelin is an analog of luteinizing hormone-releasing hormone, long-term use of this product can inhibit the synthesis of pituitary luteinizing hormone, thus causing a decline...

Friday 22 August 2025

The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement is...

Saturday 19 July 2025

Goserelin is a gonadorelin analog with similar effects, and was approved for marketing in France in 1987. Goserelin is an analog of luteinizing hormone-releasing hormone, long-term use of this product can inhibit the synthesis of pituitary luteinizing hormone, thus causing a decline...

Saturday 19 July 2025

The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement is...

Thursday 17 July 2025

Goserelin 是一种具有类似作用的促那瑞林类似物，于 1987 年在法国获准上市。戈舍瑞林是黄体生成素释放激素的类似物，长期使用本品可抑制垂体黄 体生成素的合成，从而引起男性血清睾酮和女性血清雌二醇的下降，停用此作用后可逆转， 初次使用本品可暂时增加男性血清睾酮浓度和女性血清雌二醇浓度。在男性患者中，血清睾 酮浓度在首次注射该药物后约 21 天降至贮库水平，并在随后的治疗中维持在这些水平，这导致大多数患者的前列腺肿瘤消退 和症状改善。在女性患者中，血清雌二醇浓度在初始给药后约 21 天受到抑制，并在后续治疗中每 28 天维持在绝经后水平。本品的半衰期为...

Thursday 17 July 2025

The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement...

Tuesday 15 July 2025

​​​​​​​The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement...

Friday 11 July 2025

Goserelin 是一种具有类似作用的促那瑞林类似物，于 1987 年在法国获准上市。戈舍瑞林是黄体生成素释放激素的类似物，长期使用本品可抑制垂体黄 体生成素的合成，从而引起男性血清睾酮和女性血清雌二醇的下降，停用此作用后可逆转， 初次使用本品可暂时增加男性血清睾酮浓度和女性血清雌二醇浓度。在男性患者中，血清睾 酮浓度在首次注射该药物后约 21 天降至贮库水平，并在随后的治疗中维持在这些水平，这导致大多数患者的前列腺肿瘤消退 和症状改善。在女性患者中，血清雌二醇浓度在初始给药后约 21 天受到抑制，并在后续治疗中每 28 天维持在绝经后水平。本品的半衰期为...

Friday 11 July 2025

The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement...

Tuesday 01 July 2025

Goserelin is a gonadorelin analog with similar effects, and was approved for marketing in France in 1987. Goserelin is an analog of luteinizing hormone-releasing hormone, long-term use of this product can inhibit the synthesis of pituitary luteinizing hormone, thus causing a decline...

Tuesday 01 July 2025

Goserelin is a gonadorelin analog with similar effects, and was approved for marketing in France in 1987. Goserelin is an analog of luteinizing hormone-releasing hormone, long-term use of this product can inhibit the synthesis of pituitary luteinizing hormone, thus causing a decline...

Tuesday 01 July 2025

The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement is...

Wednesday 25 June 2025

Goserelin is a gonadorelin analog with similar effects, and was approved for marketing in France in 1987. Goserelin is an analog of luteinizing hormone-releasing hormone, long-term use of this product can inhibit the synthesis of pituitary luteinizing hormone, thus causing a decline...

Wednesday 25 June 2025

The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement is...

Tuesday 24 June 2025

Goserelin is a gonadorelin analog with similar effects, and was approved for marketing in France in 1987. Goserelin is an analog of luteinizing hormone-releasing hormone, long-term use of this product can inhibit the synthesis of pituitary luteinizing hormone, thus causing a decline...

Tuesday 24 June 2025

The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement is...